OVERVIEW
Vic Market Research Co., Ltd. is pleased to announce the release of the “Global and Chinese Bi-Specific Antibodies Therapy Market Insight Report 2025–2031.”
This comprehensive study is designed to provide a structured and in-depth analysis of the Bi-Specific Antibodies Therapy industry, both domestically and internationally, with a focus on the following key areas:
1.An overview and assessment of the current development status and emerging trends in the Bi-Specific Antibodies Therapy industry across global and Chinese markets.
2.Estimation of the overall market size of the Bi-Specific Antibodies Therapy industry, along with a detailed analysis of market share by major countries.
3.Evaluation of the development potential within various segments of the Bi-Specific Antibodies Therapy industry, analysis of downstream market demand, and an examination of the competitive landscape.
4.Identification and exploration of industry pain points, aiming to support stakeholders in addressing key challenges effectively.
This report integrates extensive desk research with qualitative interviews conducted with industry experts and insiders, ensuring both the objectivity and comprehensiveness of the findings and data.
The study provides a detailed examination of the production, consumption, import, and export dynamics of the Bi-Specific Antibodies Therapy market in China. It also highlights key global and domestic manufacturers that play a significant role in the Chinese market, presenting core performance indicators such as sales volume, revenue, pricing, gross margin, and market share.
Furthermore, the report delivers a thorough analysis of segmented growth within the Bi-Specific Antibodies Therapy product category, including differentiation by product types, pricing, sales, revenue, and application-specific market performance. Historical data from 2020 to 2024 is incorporated, with forward-looking projections extending through 2031.
In light of the significant uncertainty introduced by the U.S. tariff policy set to take effect in 2025, the report offers a dedicated analysis of its core impacts. This includes assessments of global and regional competitive dynamics, economic linkages, supply chain restructuring, and countries’ strategic responses. The report concludes with strategic recommendations and a forward-looking outlook for the Bi-Specific Antibodies Therapy market.
1. Key Global Players in the Bi-Specific Antibodies Therapy Industry:
Roche
Amgen
Sanofi
Pfizer
Johnson & Johnson
AstraZeneca
AbbVie
Lindis Biotech
MacroGenics, Inc
Genmab
Alphamab Co. Ltd
Akeso, Inc.
2.Global Bi-Specific Antibodies Therapy Market, Segmented by Product Type:
Fragment-Based Antibodies
IgG-Based Antibodies
3. Global Bi-Specific Antibodies Therapy Market, Segmented by Application
Cancer
Haemophilia
Other Non-Cancer Diseases
4. Global Bi-Specific Antibodies Therapy Market, by Geographical Region:
North America (USA and Canada)
Europe (Germany, UK, France, Italy and other European countries)
Asia-Pacific (China, Japan, Korea, Taiwan, Southeast Asia, India, etc.)
Latin America (Mexico and Brazil, etc.)
Middle East and Africa (Turkey and Saudi Arabia, etc.)
I. Bi-Specific Antibodies Therapy Market Overview:
1.1 Product Definition and Statistical Scope
1.2 On the basis of different product types, Bi-Specific Antibodies Therapy can be mainly categorized as follows:
Global Growth Trend of Bi-Specific Antibodies Therapy by Product Type 2020 VS 2024 VS 2031
Fragment-Based Antibodies
IgG-Based Antibodies
1.3 From different applications, Bi-Specific Antibodies Therapy mainly includes the following:
Global Different Applications Bi-Specific Antibodies Therapy Growth Trend 2020 VS 2024 VS 2031
Cancer
Haemophilia
Other Non-Cancer Diseases
1.4 Global Bi-Specific Antibodies Therapy Development Status and Future Trends (2020-2031)
Global Market Bi-Specific Antibodies Therapy Revenue and Growth Rate (2020-2031)
Global Market Bi-Specific Antibodies Therapy Sales and Growth Rate (2020-2031)
II. Global Market Major Bi-Specific Antibodies Therapy Manufacturers Analysis:
2.1 Global Market Key Manufacturers Bi-Specific Antibodies Therapy Sales and Market Share
Global Market Key Manufacturers Bi-Specific Antibodies Therapy Sales (2020-2025)
Global Market Major Manufacturers Bi-Specific Antibodies Therapy Sales Market Share (2020-2025)
2.2 Global Market Key Manufacturers Bi-Specific Antibodies Therapy Revenue and Market Share
Global Market Key Manufacturers Bi-Specific Antibodies Therapy Revenue (2020-2025)
Global Market Key Manufacturers Bi-Specific Antibodies Therapy Revenue Market Share (2020-2025)
Global Market Key Manufacturers Bi-Specific Antibodies Therapy Revenue Ranking by 2024
2.3 Global Market Key Manufacturers Bi-Specific Antibodies Therapy Price (2020-2025)
2.4 Global Market Major Manufacturers Bi-Specific Antibodies Therapy Headquarter and Origin Distribution
2.5 Global Market Key Manufacturers Bi-Specific Antibodies Therapy Establishment Date and Bi-Specific Antibodies Therapy Commercialization Date
2.6 Global Market Major Manufacturers Bi-Specific Antibodies Therapy Product Type and Application
2.7 Bi-Specific Antibodies Therapy Industry Concentration, Competition Analysis
Bi-Specific Antibodies Therapy Industry Concentration Analysis: Global Top 5 Manufacturers Market Share by 2024
Global Market Bi-Specific Antibodies Therapy First Tier, Second Tier and Third Tier Manufacturers (Brand) and Market Share in 2024.
2.8 New Investments and Market M&A Activities
III. Profiles of the following key players:
Roche
Amgen
Sanofi
Pfizer
Johnson & Johnson
AstraZeneca
AbbVie
Lindis Biotech
MacroGenics, Inc
Genmab
Alphamab Co. Ltd
Akeso, Inc.
1. Basic Information, Bi-Specific Antibodies Therapy Manufacturing Base, Headquarters, Competitors and Market Position.
2. Bi-Specific Antibodies Therapy Product Specifications, Parameters, and Market Applications .
3. Bi-Specific Antibodies Therapy Sales, Revenue, Price and Gross Margin in Global Market (2020-2025).
4. Company Profile and Key Businesses.
5. Latest Company News.
IV. Analysis of Different Product Types of Bi-Specific Antibodies Therapy:
4.1 Global Market Bi-Specific Antibodies Therapy Sales by Product Type (2020-2031)
Global Market Sales and Market Share of Bi-Specific Antibodies Therapy by Product Type (2020-2025)
Global Market Sales Forecast of Bi-Specific Antibodies Therapy by Different Product Types (2026-2031)
4.2 Global Market Bi-Specific Antibodies Therapy Size by Product Type (2020-2031)
Global Market Bi-Specific Antibodies Therapy Size and Market Share by Product Type (2020-2025)
Global Market Size Forecast of Bi-Specific Antibodies Therapy by Product Type (2026-2031)
4.3 Global Market Price Trend of Bi-Specific Antibodies Therapy by Product Type (2020-2031)
V. Analysis of Bi-Specific Antibodies Therapy for Different Applications
5.1 Global Market Sales of Bi-Specific Antibodies Therapy by Application (2020-2031)
Global Market Bi-Specific Antibodies Therapy Sales and Market Share by Application (2020-2025)
Global Market Bi-Specific Antibodies Therapy Sales Forecast by Application (2026-2031)
5.2 Global Market Bi-Specific Antibodies Therapy Size and Market Share by Application (2020-2025)
Global Market Bi-Specific Antibodies Therapy Size Forecast by Application (2026-2031)
5.3 Global Market Price Trend of Bi-Specific Antibodies Therapy by Application (2020-2031)
VI. Industry Development Environment Analysis
6.1 Development Analysis of Bi-Specific Antibodies Therapy Industry - Development Trend
6.2 Bi-Specific Antibodies Therapy Industry Development Analysis - Manufacturer Barriers
6.3 Bi-Specific Antibodies Therapy Industry Development Analysis - Driving Factors
6.4 Bi-Specific Antibodies Therapy Industry Development Analysis - Restraints
6.5 SWOT Analysis of Bi-Specific Antibodies Therapy Global Companies
6.6 Bi-Specific Antibodies Therapy Industry Development Analysis - Industry Policies
Industry Authorities and Regulatory Framework
Industry-related Policy Trends
Industry Related Planning
VII. Industry Supply Chain Analysis
7.1 Industry Chain Introduction of Bi-Specific Antibodies Therapy Industry
7.2 Bi-Specific Antibodies Therapy Industry Chain Analysis - Upstream
7.3 Bi-Specific Antibodies Therapy Industry Chain Analysis - Midstream
7.4 Bi-Specific Antibodies Therapy Industry Chain Analysis - Downstream
7.5 Procurement Mode of Bi-Specific Antibodies Therapy Industry
7.6 Production Mode of Bi-Specific Antibodies Therapy Industry
7.7 Bi-Specific Antibodies Therapy Industry Sales Model and Sales Channels
VIII. Global Local Bi-Specific Antibodies Therapy Capacity, Production Analysis
8.1 Global Bi-Specific Antibodies Therapy Supply and Demand Status and Forecast (2020-2031)
Global Bi-Specific Antibodies Therapy Capacity, Production, Capacity Utilization and Development Trend (2020-2031)
Global Bi-Specific Antibodies Therapy Production, Market Demand and Development Trend (2020-2031)
8.2 Global Bi-Specific Antibodies Therapy Import and Export Analysis
Global Market Bi-Specific Antibodies Therapy Main Import Sources
Global Market Bi-Specific Antibodies Therapy Main Export Destinations
IX. Research Findings and Conclusion
X. Appendix
10.1 Research Methodology
10.2 Data Sources
Secondary Information Sources
Primary Information Sources
10.3 Data Interactive Validation
10.4 Disclaimer”
Table of Contents
Table : Growth Trends in Bi-Specific Antibodies Therapy by Product Type
Table:Growth Trend of Different Applications
Table:Current Development Status of Bi-Specific Antibodies Therapy Industry
Table:Development Trend of Bi-Specific Antibodies Therapy
Table:Global Major Regions Production of Bi-Specific Antibodies Therapy
Table:Global Major Regions Bi-Specific Antibodies Therapy Production Market Share
Table:Global Market Major Manufacturers Bi-Specific Antibodies Therapy Production Capacity
Table:Global Market Major Manufacturers Bi-Specific Antibodies Therapy Sales, Sales Market Share, Sales Revenue
Table:Global Market Major Manufacturers Bi-Specific Antibodies Therapy Sales Revenue Market Share, Price
Table: Global Key Manufacturers Bi-Specific Antibodies Therapy Revenue Ranking by 2025
Table: China Market Major Manufacturers Bi-Specific Antibodies Therapy Sales, Sales Market Share, Sales Revenue
Table: China Market Key Manufacturers Bi-Specific Antibodies Therapy Sales Revenue Market Share, Sales Price
Table: China Key Manufacturers Bi-Specific Antibodies Therapy Revenue Ranking by 2025
Table: Global Major Manufacturers Bi-Specific Antibodies Therapy Production Distribution and Commercialization Date
Table:Global Major Manufacturers Bi-Specific Antibodies Therapy Product Type List
Table: Global Key Manufacturers Market Position of Bi-Specific Antibodies Therapy in 2025 (First Tier, Second Tier and Third Tier)
Table: Global Bi-Specific Antibodies Therapy Market Analysis of Current Status of Investments, Mergers & Acquisitions, and Others
Table: Global Major Regions Bi-Specific Antibodies Therapy Sales Revenue
Table: Global Major Regions Bi-Specific Antibodies Therapy Sales Revenue Market Share
Table: Global Major Regions Bi-Specific Antibodies Therapy Revenue Market Share
Table: Global Major Regions Bi-Specific Antibodies Therapy Sales Volume
Table: Global Major Regions Bi-Specific Antibodies Therapy Sales Market Share
Table : Global Major Regions Bi-Specific Antibodies Therapy Sales Share
Table : The following companies:
Roche
Amgen
Sanofi
Pfizer
Johnson & Johnson
AstraZeneca
AbbVie
Lindis Biotech
MacroGenics, Inc
Genmab
Alphamab Co. Ltd
Akeso, Inc.
Bi-Specific Antibodies Therapy Manufacturing Base, Sales Area, Competitors and Market Position
Bi-Specific Antibodies Therapy Product Specifications, Parameters and Market Applications
Bi-Specific Antibodies Therapy Sales, Revenue, Price and Gross Margin
Company Profile and Major Businesses
Latest Company News
Table: Global Sales of Bi-Specific Antibodies Therapy by Product Type
Table: Global Sales Market Share of Bi-Specific Antibodies Therapy by Product Type
Table: Global Sales Forecast of Bi-Specific Antibodies Therapy by Product Type
Table: Global Sales Market Share Forecast of Bi-Specific Antibodies Therapy by Product Type
Table: Global Revenue of Bi-Specific Antibodies Therapy by Product Type
Table: Global Bi-Specific Antibodies Therapy Revenue Market Share by Product Type
Table: Global Revenue Forecast of Bi-Specific Antibodies Therapy by Product Type
Table: Global Revenue Market Share Forecast of Bi-Specific Antibodies Therapy by Product Type
Table: Global Price Trend of Bi-Specific Antibodies Therapy by Product Type
Table: Global Sales of Bi-Specific Antibodies Therapy by Application
Table: Global Sales Market Share of Bi-Specific Antibodies Therapy by Application
Table: Global Sales Forecast of Bi-Specific Antibodies Therapy by Application
Table: Global Bi-Specific Antibodies Therapy Sales Market Share Forecast by Application
Table: Global Bi-Specific Antibodies Therapy Revenue by Application
Table: Global Bi-Specific Antibodies Therapy Revenue Market Share by Application
Table: Global Bi-Specific Antibodies Therapy Revenue Forecast by Application
Table: Global Bi-Specific Antibodies Therapy Revenue Market Share Forecast by Application
Table: Global Price Trend of Bi-Specific Antibodies Therapy by Application
Table: List of Bi-Specific Antibodies Therapy Upstream Raw Material Suppliers and Contact Information
Table: List of Typical Customers of Bi-Specific Antibodies Therapy
Table: Bi-Specific Antibodies Therapy Main Sales Modes and Sales Channels
Table: Development Opportunities and Key Driving Factors of Bi-Specific Antibodies Therapy Industry
Table: Risks Faced by Bi-Specific Antibodies Therapy Industry Development
Table: Bi-Specific Antibodies Therapy Industry Policy Analysis
Table: Research Scope
Table: List of Analysts
Chart Catalog
Figure Bi-Specific Antibodies Therapy Product Picture
Figure Global Production Market Share of Bi-Specific Antibodies Therapy by Product Type
Figure Global Bi-Specific Antibodies Therapy Consumption Market Share by Application
Figure Global Bi-Specific Antibodies Therapy Capacity, Production, Capacity Utilization and Development Trend
Figure Global Bi-Specific Antibodies Therapy Production, Demand and Development Trend
Figure Global Bi-Specific Antibodies Therapy Production Market Share by Major Regions
Figure China Bi-Specific Antibodies Therapy Capacity, Production, Capacity Utilization and Development Trend
Figure China Bi-Specific Antibodies Therapy Production, Market Demand and Development Trend
Figure Global Bi-Specific Antibodies Therapy Market Sales and Growth Rate.
Figure Global Bi-Specific Antibodies Therapy Market Size
Figure Global Market Bi-Specific Antibodies Therapy Sales and Growth Rate
Figure Global Market Bi-Specific Antibodies Therapy Price Trend
Figure Global Market Bi-Specific Antibodies Therapy Sales Market Share of Major Manufacturers in 2025
Figure Bi-Specific Antibodies Therapy Revenue Market Share of Key Manufacturers in Global Market in 2025
Figure Bi-Specific Antibodies Therapy Sales Market Share of Key Manufacturers in China Market in 2025
Figure Bi-Specific Antibodies Therapy Revenue Market Share of Key Manufacturers in China Market, 2025
Figure 2025 Global Bi-Specific Antibodies Therapy Market Share of Top 5 Manufacturers
Figure 2025 Global Bi-Specific Antibodies Therapy First Tier, Second Tier and Third Tier Manufacturers (by Brand) and Market Share
Figure Global Bi-Specific Antibodies Therapy Sales Revenue Market Share by Major Regions
Figure North America Bi-Specific Antibodies Therapy Sales and Growth Rate
Figure North America Bi-Specific Antibodies Therapy Revenue and Growth Rate
Figure Europe Market Bi-Specific Antibodies Therapy Sales and Growth Rate
Figure Europe Market Bi-Specific Antibodies Therapy Revenue and Growth Rate
Figure China Bi-Specific Antibodies Therapy Sales and Growth Rate
Figure China Market Bi-Specific Antibodies Therapy Revenue and Growth Rate
Figure Bi-Specific Antibodies Therapy Sales and Growth Rate in Japan Market
Figure Bi-Specific Antibodies Therapy Revenue and Growth Rate in Japan Market
Figure Global Price Trend of Bi-Specific Antibodies Therapy by Product Type
Figure Global Price Trend of Bi-Specific Antibodies Therapy by Application
Figure Bi-Specific Antibodies Therapy Industry Chain
Figure Bi-Specific Antibodies Therapy Chinese Companies SWOT Analysis
Figure Key Interview Objectives
The research methodology employed by VICResearch has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of VICResearch. VICResearch’s methodology can be divided into five stages:
Stage 1: Secondary research
The research team first works with magazines, industry trade group, and administration that operate in the research field. The information provided by our in-house documentation service helps us carrying out further research. Our team which has the experience as well as the knowledge efficiently extracts the accurate information from existing source.
Stage 2: Primary research: interviews with trade sources
After the first stage, the research team conducts large number of face-to-face or telephone interviews with the representative companies operating in the research field. The analysts attempt to obtain a chance to talk with leading players in the field as well as with small companies. The upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers are all included in the interviews. The data gathered during the interview is then carefully checked and compared with the secondary research.
Stage 3: Analysis of the gathered data
The analysis team checks and synthesizes the data gathered during the first two stages. To validate the data, a second series of interviews can be conducted.
Stage 4: Quantitative data
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by VICResearch. The data is based on the estimates obtained during stage 3.
The research team also provides appreciation and analysis of the market and the quantitative data contained in the reports. The data is consequently unique to VICResearch.
Stage 5: Quality control
Before publishing, every report goes under a rigorous checking and editing process, which is done by experience management team to ensure the reliability of the published data. Each analyst in the research team receives support and on-going training which is part of the VICResearch’s internal quality process.
2025-04-19 13:20:58 
Pages: 106 
Tables: 134 
